STOCK TITAN

PTCT (NASDAQ: PTCT) insider reports proposed 2,662-share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Matthew Klein reported proposed and recent sales of Common Stock. The filing lists a proposed sale of 2,662 shares on 03/11/2026 tied to restricted stock vesting. The filing also records multiple sales in the prior three months, including 8,089 shares on 12/30/2025 and 7,371 shares on 02/18/2026, with dollar amounts shown for each trade.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the PTCT Form 144 disclose about Matthew Klein's transactions?

The Form 144 discloses a proposed sale of 2,662 shares on 03/11/2026 related to restricted stock vesting. It also lists multiple completed sales in the prior three months with dates, share counts, and proceeds for each trade.

How many shares did Matthew Klein sell on 12/30/2025 according to the filing?

On 12/30/2025 the filing shows a sale of 8,089 shares with proceeds of $619,921.55. That trade is one of several listed during the three-month period preceding the Form 144 filing.

Does the filing explain why 2,662 shares are being sold on 03/11/2026?

Yes. The filing ties the 2,662-share proposed sale on 03/11/2026 to restricted stock vesting, and classifies the source as Issuer / Compensation in the securities-to-be-sold section.

What proceeds are shown for the sale on 02/18/2026 in the Form 144?

The Form 144 records a sale on 02/18/2026 of 7,371 shares with proceeds of $511,227.50. Each completed sale in the filing lists the trade date, share amount, and gross proceeds.
Ptc Therapeutics

NASDAQ:PTCT

View PTCT Stock Overview

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

5.44B
76.39M
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN